Oriental Aromatics Ltd Q2FY26 Concall Decoded – Record Sales, Margin Malaise & Mahad’s Moody Chemistry

1. Opening Hook

What’s common between your perfume, camphor tablet, and this earnings call? They all smell nice until someone mentions “margins.” 💨

Oriental Aromatics delivered its highest-ever quarterly sales — and yet, profits looked like someone forgot to add fragrance base to the mix. A booming festive season, Chinese “dumping diplomacy,” and Mahad’s underutilized plant all came together for a quarter that’s half sweet, half sinus medicine.

Stick around — because when management says “buyer’s market,” they’re not talking about retail therapy.

2. At a Glance

• Revenue ₹271 Cr, up 20% QoQ: Sales finally perfumed the P&L.
• EBITDA ₹17 Cr, margin 6.34%: Growth smells great, margins not so much.
• PAT ₹0.74 Cr: Profit faintly detectable — like base notes in cheap perfume.
• Production up 26% QoQ: Mahad, Baroda, and Ambernath in overdrive.
• Debt-to-Equity 0.6x: Conservative balance sheet, aggressive chemistry.
• H1 Revenue ₹497 Cr, up 10% YoY: Half-year strength, half-year strain.

3. Management’s Key Commentary

“We achieved our highest-ever quarterly sales and 26% growth in production.”
(Translation: Volume party, profit hangover.)

“Margins are lower, but that’s a conscious choice to protect market share.”
(The perfume industry’s version of ‘we meant to do that.’) 😏

“Chinese suppliers are flooding non-tariff markets like India and EU.”
(So basically, price wars with pandas.)

“Mahad plant caused a 1.5–2% drag on EBITDA.”
(Mahad’s still in startup mode — burning cash and chemicals.)

“We’ll restore EBITDA margins to 8–10% through process re-engineering.”
(When in doubt, add a Six Sigma slide.)

“Camphor and terpene division performed strongly, supported by festive demand.”
(Nothing like Diwali pujas to save the quarter.)

“We’re not approaching authorities for anti-dumping yet; we’re watching.”
(Aromatics diplomacy in action.)

4. Numbers Decoded